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Abstract
Background: During the course of normal cellular metabolism, oxygen is consumed and reactive oxygen species
(ROS) are produced. If not effectively dissipated, ROS can accumulate and damage resident proteins, lipids, and
DNA. Enzymes involved in redox regulation and DNA repair dissipate ROS and repair the resulting damage in order
to preserve a functional cellular environment. Because increased ROS accumulation and/or unrepaired DNA
damage can lead to initiation and progression of cancer and we had identified a number of oxidative stress and
DNA repair proteins that influence estrogen responsiveness of MCF-7 breast cancer cells, it seemed possible that
these proteins might be differentially expressed in normal mammary tissue, benign hyperplasia (BH), ductal
carcinoma in situ (DCIS) and invasive breast cancer (IBC).
Methods: Immunohistochemistry was used to examine the expression of a number of oxidative stress proteins,
DNA repair proteins, and damage markers in 60 human mammary tissues which were classified as BH, DCIS or IBC.
The relative mean intensity was determined for each tissue section and ANOVA was used to detect statistical
differences in the relative expression of BH, DCIS and IBC compared to normal mammary tissue.
Results: We found that a number of these proteins were overexpressed and that the cellular localization was
altered in human breast cancer tissue.
Conclusions: Our studies suggest that oxidative stress and DNA repair proteins not only protect normal cells from
the damaging effects of ROS, but may also promote survival of mammary tumor cells.
Background
The multistep model of human breast cancer progres-
sion suggests that invasive breast cancer (IBC) develops
in a stepwise manner from premalignant hyperplasia to
ductal carcinoma in situ (DCIS) to metastatic carcinoma
[1]. Benign hyperplasia (BH), which involves the prolif-
eration of epithelial cells, commonly develops with aging
and may increase the risk of breast cancer [2]. DCIS,
the most common non-invasive form of breast cancer, is
an abnormal proliferation of epithelial cells confined to
the ducts. However, 1-2% of DCIS patients progress to
IBC as cells begin to invade the basement membrane.
Once the basement membrane has been breached, cells
can migrate from the primary tumor through the blood
stream to secondary sites where the cells colonize.
Metastatic cancer is the leading cause of cancer-related
morbidity and mortality [3,4].
It has been suggested that aging results from exposure
of cellular macromolecules to reactive oxygen species
(ROS) and that accumulation of ROS-induced damage is
responsible for the development of diseases associated
with aging, including cancer [5-9]. Oxidative stress
response proteins are neededt op r e v e n tt h ea c c u m u l a -
tion of ROS, which include superoxide, hydrogen perox-
ide and hydroxy radical. Cu/Zn superoxide dismutase
(SOD1) helps to regulate ROS levels by converting
superoxide to hydrogen peroxide, which can then be
converted to H2O (Fig. 1, Ref [10]). If not effectively dis-
sipated, intracellular ROS accumulation can result in
nitration and/or oxidation of cellular proteins including
numerous transcription factors [11-13]. Other proteins
involved in redox regulation including thioredoxin
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any medium, provided the original work is properly cited.(Trx), thioredoxin reductase (TrxR) and apurinic/apyri-
midinic endonuclease 1/redox factor-1 (Ape1/Ref-1) are
important in reducing oxidized cellular proteins and
play critical roles in maintaining transcription factor
activity [12-14]. Similarly, protein disulfide isomerase
( P D I )a c t sa sam o l e c u l a rc haperone to maintain the
structural integrity of numerous proteins including
estrogen receptor a (ERa, Refs [13,15]). We have shown
that together, these oxidative stress proteins form an
interactive network and that they act collectively to reg-
ulate oxidative stress and maintain a functional cellular
environment [15-18].
Oxidative stress can produce DNA lesions such as
8-oxoguanine (8-OxoG), which are recognized and
removed by cellular DNA glycosylases leaving abasic
sites. Likewise, alkylating agents can convert guanine
residues to 3-methylguanines, which are removed by the
DNA repair protein 3-methyladenine DNA glycosylase
(MPG) to produce abasic sites. The abasic sites are
recognized by Ape1/Ref-1, which cleaves the adjacent
DNA backbone to continue the DNA repair process
[19,20]. However, if abasic sites accumulate, double-
stranded DNA breaks can occur [21]. The histone
H2AX is rapidly phosphorylated when double-stranded
breaks are formed and subsequently acts to recruit DNA
repair proteins [22,23]. If damaged DNA is not repaired,
genomic integrity can be compromised and unrestrained
proliferation of aberrant cells may occur [9,24].
Our laboratory identified oxidative stress (SOD1,
Ape1/Ref-1, Trx, TrxR and PDI) and DNA repair
Figure 1 Role of oxidative stress and DNA repair proteins in cells. NM23-H1 induced DNA nicks may lead to DNA repair or apoptosis.
Endogenous or exogenous alkylating agents cause DNA lesions such as 3-methylguanine (3-MeG), which are recognized and removed by MPG
and leave apurinic sites. Ape1/Ref-1 recognizes apurinic sites and cleaves the adjacent DNA backbone. DNA repair can be completed through
the base excision repair pathway. If not repaired, apurinic sites can result in double-stranded breaks. g-H2AX associates with double-stranded
breaks and recruits DNA repair proteins. Reactive oxygen species (ROS), which include superoxide (O2
–·), hydrogen peroxide (H2O2), and hydroxyl
radical (OH
·), are formed as byproducts of normal cellular metabolism and can produce DNA lesions such as 8-OxoG, which are excised by
cellular DNA glycosylases. Accumulated O2 interacts with nitric oxide (NO
·) to produce peroxynitrite (OONO
–), which in turn nitrates tyrosines and
alters protein structure/function. TrxR uses NADPH to reduce Trx, which in turn reduces and activates Ape1/Ref-1. Activated Ape1/Ref-1 reduces a
number of proteins including various transcription factors.
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with the DNA-bound ERa [15-18,25,26] and showed
that each of these proteins influences estrogen-respon-
sive gene expression in MCF-7 human breast cancer
cells. Because it seemed possible that dysregulation of
any one of these proteins might result in increased ROS
accumulation and/or unrepaired DNA damage and
could feasibly promote oncogenesis, we examined their
expression as well as the damage markers 8-OxoG,
g-H2AX and nitrotyrosine, in normal mammary tissue,
BH, DCIS and IBC.
Methods
Tissue
Ten serial sections of 60 mammary tissues, which were
classified by a board certified pathologist as BH, DCIS
or IBC, were obtained from Carle Foundation Hospital
(Urbana, IL). These tissues were procured from biopsies
performed and archived in 2007 from female patients
ranging in age from 26 to 88 years old. Patient charac-
teristics are summarized in Table 1. Normal mammary
tissues were obtained from 37 and 81 year old females
and had very similar protein localization and expression
patterns. This study was approved by the Institutional
Review Boards of the University of Illinois at Urbana-
Champaign (06171) and Carle Foundation Hospital
(05-44). The identity of all patients is the sole property
of Carle Foundation Hospital and has not been nor will
it in the future be shared with the investigators.
Immunohistochemistry
Paraffin-embedded blocks were sectioned and mounted
on frost-free slides. The 3-10 μm sections were deparaf-
finized in xylene and rehydrated through a series of
graded alcohols. Slides were washed with 1× PBS and
endogenous peroxidases were blocked with 1.5% hydro-
gen peroxide in 1× PBS for 20 min at 25°C. After three
5 min washes in 1× PBS, slides were incubated in block-
ing solution (1× PBS with 0.1% Triton X-100, 3% bovine
serum albumin) with 5% normal donkey serum for 10
min at 25°C. Control (no primary antibody) and experi-
mental slides were incubated overnight at 4°C, respec-
tively, in blocking solution alone or blocking solution
with SOD1 (1:400, sc-11407; Santa Cruz Biotechnology,
Santa Cruz CA), Ape1/Ref-1 (1:400, sc-17774; Santa
Cruz Biotechnology, Santa Cruz CA), PDI (1:200, sc-
30932; Santa Cruz Biotechnology, Santa Cruz CA), Trx
(1:400, ab16835; Abcam, Cambridge MA), TrxR (1:400,
ab16840; Abcam, Cambridge MA), NM23-H1 (1:400, sc-
343; Santa Cruz Biotechnology, Santa Cruz CA), MPG
(1:600, ab55461; Abcam, Cambridge MA), 8-oxoguanine
(1:400, ab64548; Abcam, Cambridge MA), g-H2AX
(1:1000, ab2893; Abcam, Cambridge MA), or nitrotyro-
sine (1:800, 06-284; Millipore, Billerica MA) antibody.
Biotin-conjugated secondary antibody (1:200; Jackson
ImmunoResearch, West Grove PA) was added and slides
were incubated at 25°C for 30 min and then washed
three times with 1× PBS. The ABC Peroxidase Staining
kit (1:100 dilution of each Reagent A and B in 1× PBS,
32020; Thermo Scientific, Rockford IL) was applied at
25°C for 30 min. After 3 washes with 1× PBS, staining
was visualized with peroxidase-sensitive Sigmafast 3,3’-
Diaminobenzidine tablets (DAB; Sigma, St. Louis MO).
Exposure times were synchronized so that all tissues
samples within an antibody group were exposed to DAB
for the exact same time. All slides were counterstained
with 0.1% methyl green (Sigma, St. Louis MO) for 3
min at 60°C, dehydrated in ethanol, cleared in xylene
and mounted with Permount (Fisher Scientific, Pitts-
burgh PA). Images were obtained at 40× using a Leica
DMI4000B confocal microscope with the Retiga 2000R
digital camera. Exposure times were kept constant for
all samples.
Data Analysis
For each antibody, at least five sections of normal mam-
mary tissue were stained in parallel with BH, DCIS and
IBC sections. Approximately 20 images from 5-6 normal
mammary sections (2-3 sections from each normal
patient) and 6-8 images for each BH, DCIS or IBC sec-
tion were collected for a total of ~4500 images. All
images were analyzed using Image Pro Plus software
(Media Cybernetics, Bethesda MD). The total intensity
of staining and the area covered by whitespace (non-tis-
sue) was recorded for each image (6-8 images/slide).
A script was written to analyze multiple images conse-
cutively and all data was exported to Excel (Microsoft,
Redmond WA) for analysis. To determine the area cov-
ered by tissue in each image, whitespace (non-tissue)
area was subtracted from the total area of the image.
The intensity per area was determined by dividing the
total staining intensity by the tissue area calculated for
each image and averaging the 6-8 images taken for each
tissue sample. To determine relative intensity per area,
the mean intensity per area determined for each tissue
sample was compared to the mean intensity per area of
the normal tissue samples. Cellular localization (cyto-
plasm, nucleus or both) and tissue distribution (stroma,
Table 1 Patient characteristics
Clinicopathologic Data Number Percentage (%)
Patient Age
<40 years old 14 23.3
40-60 years old 24 40.0
>60 years old 22 36.7
Histologic classification
Benign Hyperplasia 16 26.7
Ductal Carcinoma In Situ 17 28.3
Invasive Breast Cancer 27 45.0
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tion of 6-8 fields per sample.
Results
Normal mammary tissue was used initially to optimize
conditions for detection of the oxidative stress and
DNA repair proteins. However, because the expression
of the damage markers was undetectable in normal
mammary tissue, IBC sections were utilized. To ensure
that the expression patterns observed were due to the
specificity of the primary antibody and were not pro-
duced by non-specific secondary antibody binding,
immunohistochemistry (IHC) was performed without
primary antibody or with antibodies which had been
preabsorbed using purified protein or peptide containing
an antibody-specific epitope (Fig. 2 and data not
shown). No background staining was produced with the
rabbit, mouse or goat secondary antibodies used in the
experiments described herein.
The expression of the oxidative stress proteins (SOD1,
Ape1/Ref-1, Trx, TrxR, and PDI), the DNA repair pro-
teins (Ape1/Ref-1, NM23-H1 and MPG), and the
damage markers (8-OxoG, g-H2AX and nitrotyrosine)
were examined in 60 mammary tissues that were classi-
fied as BH, DCIS or IBC. The characteristics of the 26
to 88 year old female patients from whom the tissues
were obtained are summarized in Table 1.
Oxidative stress proteins
In normal human mammary tissue, SOD1 was primarily
localized in the nucleus and was present in both epithe-
lial and stromal cells (Fig. 3A). Although there was no
significant change in SOD1 expression in BH compared
to normal mammary tissue, quantitative analysis of
staining intensity indicated that 69% (11/15) of DCIS
and 72% (18/25) of IBC tissues examined had higher
SOD1 expression than normal mammary tissue (Fig. 3A
and 3B).
Ape1/Ref-1 expression was increased in 92% (12/13)
of DCIS and 86% (19/22) of IBC tissues compared to
normal mammary tissue (Fig. 4A and 4B). Although
Ape1/Ref-1 was mainly restricted to the epithelial cell
nuclei in normal tissue and BH, it was present in the
cytoplasm and nuclei of DCIS and IBC tissues (Fig. 4C).
Thus, there was a redistribution of Ape1/Ref-1 from the
nuclear to the cytoplasmic compartment in the malig-
nant breast cancer cells.
Although Trx expression was similar in normal mam-
mary tissue and BH (Fig. 5), 80% (12/15) of DCIS and
95% (21/22) of IBC tissues had greater than normal
expression (Fig. 5A and 5B) indicating that Trx was
overexpressed in mammary tumors. Analysis of Trx
expression in normal tissue indicated that it was princi-
pally localized in epithelial nuclei, but was also present
in the cytoplasm in BH, DCIS and IBC (Fig. 5C).
TrxR was primarily localized in the nuclei of stromal
and epithelial cells in normal breast tissue but was not
highly expressed (Fig. 6A). No changes in TrxR expres-
sion were observed in BH, DCIS or IBC compared to
normal breast tissue (Fig. 6A and 6B).
PDI expression was increased in 81% (13/16) of BH,
86% (13/15) of DCIS and 86% (19/22) of IBC tissues
compared to normal breast tissue (Fig. 7A and 7B).
Interestingly, PDI expression was increased more dra-
matically in ERa-positive than ERa-negative IBC
(Fig. 7C). In normal mammary tissue, PDI expression
was primarily restricted to the myoepithelial cells and,
while most (14/16) BH tissues maintained this myoe-
pithelial tissue distribution, this distinctive staining pat-
tern was lost in DCIS (9/15) and IBC (20/22) (data not
shown). Furthermore, while PDI expression was
observed in both the nucleus and cytoplasm in normal
tissue, there was a complete loss of nuclear PDI expres-
sion in IBC (Fig. 7D).
DNA repair proteins and damage markers
NM23-H1 was highly expressed in the nuclei and cyto-
plasm of epithelial and stromal cells in normal mam-
mary tissue (Fig. 8A). Although 92% (23/25) of IBC
tissues had greater than normal NM23-H1 staining (Fig.
Figure 2 Validation of IHC in normal mammary tissue. Normal mammary tissue was subjected to IHC without primary antibody but with the
secondary antibodies used to detect oxidative stress and DNA repair proteins as well as markers of protein and DNA damage. Representative
slides are shown at 40× magnification.
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Page 4 of 13Figure 3 Expression of SOD1 in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using an SOD1-specific antibody.
Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n = 16),
DCIS (n = 15) or IBC (n = 25) section and is shown graphically. ANOVA was used to detect statistical differences in the relative expression of BH,
DCIS (p = 0.0051) and IBC (p = 0.0002) compared to normal mammary tissue, where normal mammary tissue is equal to one (dashed line).
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sion had fewer positive lymph nodes (Fig. 8C). Thus,
our studies are consistent with previous work, which
described an inverse relationship between NM23-H1
expression and metastasis [27-30].
The base excision repair protein MPG was expressed
at low levels in the stromal cells of normal mammary
tissue (Fig. 9A) and was decreased in BH. MPG expres-
sion was almost completely lost in DCIS and IBC (Fig.
9A and 9B). Thus, MPG expression decreases as malig-
nancy develops.
DNA damage markers
Antibodies directed against the DNA damage markers
8-oxoguanine (8-OxoG, Fig. 10) and g-H2AX (Fig. 11)
produced little staining and thus indicate a general lack
of DNA damage in the normal mammary tissue.
Although some IBC tissues had elevated levels of 8-
OxoG, no significant alteration in 8-OxoG staining
intensity was detected in BH, DCIS or IBC compared to
normal mammary tissue (Fig. 10A and 10B). However,
8-OxoG levels were increased in ERa-positive IBC (Fig.
10C), indicating the presence of more abasic sites in
ERa-positive breast cancer. There was no significant
change in g-H2AX staining in BH, DCIS or IBC com-
pared with normal mammary tissue (Fig. 11A and 11B).
Protein damage marker
Modest stromal staining was observed in normal mam-
mary tissue indicating the presence of nitrotyrosine resi-
dues (Fig. 12A). While nitrotyrosine staining was
increased in 82% (8/13) of BH and 69% (9/13) of DCIS
tissues compared to normal breast tissue, nitrotyrosine
levels were lower than normal in 77% (20/26) of IBC tis-
sues indicating a lack of protein damage in invasive can-
cer (Fig. 12A and 12B). While this at first may seem
counter intuitive, increased expression of SOD1 in IBC
would, in fact, decrease superoxide levels, which would
in turn diminish superoxide-induced protein damage
(Fig. 1 and Ref [16]).
Figure 4 Expression of Ape1/Ref-1 in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using an Ape1/Ref-1-specific
antibody. Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n
= 13), DCIS (n = 13) or IBC (n = 22) section and is shown graphically. ANOVA was used to detect statistical differences in the relative expression
of BH, DCIS (p = 0.0002) and IBC (p < 0.0001) compared to normal mammary tissue, where normal mammary tissue is equal to one (dashed line).
C. Cellular localization of Ape1/Ref-1 expression was determined for each tissue section, classified by disease state and shown graphically (N,
nuclear; C, cytoplasmic; N+C, nuclear and cytoplasmic).
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In order to avoid ROS-induced damage to cellular
macromolecules, cells rely on a diverse array of proteins
to decrease oxidative stress and, if damage does occur,
to repair the ROS-induced damage. Oxidative stress and
DNA repair proteins promote cell survival by reducing
ROS and reversing the detrimental effects of ROS accu-
mulation. We have now shown that SOD1, Ape1/Ref-1,
Trx, PDI and NM23-H1 are overexpressed and that the
cellular localization of Ape1/Ref-1, Trx and PDI is
altered in human breast cancer tissues.
The oxidative stress proteins SOD1, Ape1/Ref-1, Trx,
TrxR, and PDI, which were first characterized in MCF-7
cells, form an interconnected network of proteins (Fig. 1
and Refs [15-18,31,32]) that help to maintain a func-
tional intracellular environment. SOD1 converts super-
oxide to hydrogen peroxide and thereby plays an
essential role in regulating intracellular ROS and limit-
ing protein and DNA damage. TrxR reduces and acti-
vates Trx. In turn, Trx reduces and activates Ape1/Ref-
1, and together Ape1/Ref-1, Trx and TrxR help to
reverse ROS-induced oxidation of numerous transcrip-
tion factors and other cellular proteins [13,14,20,33,34].
We previously demonstrated that increased SOD1
protects MCF-7 breast cancer cells from oxidative stress
[16] and now show that SOD1 expression is increased
in human breast cancer tissue. Thus, it seems plausible
that the increased SOD1 expression in DCIS and IBC
may help reduce ROS accumulation and promote cancer
cell survival. Furthermore, the capacity of SOD1 to pro-
mote angiogenesis through activation of HIF1a-
mediated VEGF expression [35,36] could potentially
play a role in tumor progression.
Increased expression of Ape1/Ref-1, Trx and TrxR has
been previously observed in human cancer [14,37-43].
Our studies provide further evidence that Ape1/Ref-1
and Trx are overexpressed in human breast cancer cells.
Both proteins play critical roles in reducing and activat-
ing the transcription factors Fos, Jun, p53, HIF1a and
NFB, which are involved in cancer progression and
promotion of cell survival [13,14,20,33,34]. Thus, the
increased expression of Ape1/Ref-1 and Trx may
Figure 5 Expression of Trx in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using a Trx-specific antibody. Representative
slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n = 16), DCIS (n = 15) or IBC
(n = 22) section and is shown graphically. ANOVA was used to detect statistical differences in the relative expression of BH, DCIS (p = 0.0039)
and IBC (p < 0.0001) compared to normal mammary tissue, where normal mammary tissue is equal to one (dashed line). C. Cellular localization of
Trx expression was determined for each tissue section, classified by disease state and shown graphically (N, nuclear; C, cytoplasmic; N+C, nuclear
and cytoplasmic).
Curtis et al. BMC Cancer 2010, 10:9
http://www.biomedcentral.com/1471-2407/10/9
Page 7 of 13contribute to the increased proliferation and angiogen-
esis and decreased apoptosis that is characteristic of
invasive breast cancer [19,44-50]. Further dysregulation
could occur as Ape1/Ref-1 and Trx are redistributed
from the nucleus to the cytoplasm in DCIS and IBC.
A previous study showed that PDI expression is
increased in invasive malignant glioma and suggested
that cytoplasmic PDI could promote cell adhesion and
play a functional role in cell migration [51]. In fact, we
observed a redistribution of PDI during oncogenesis.
Although PDI was expressed in the cytoplasm and
nucleus in normal mammary cells, nuclear PDI was
completely lost in IBC. This redistribution from the
nucleus to the cytoplasm could limit the nuclear func-
tions of PDI and contribute to tumor invasiveness.
DNA repair proteins are required to maintain normal
cell function. A loss or gain of function of any one of
these proteins could feasibly result in irrevocable harm.
The DNA glycosylase MPG recognizes and excises
damaged bases in DNA resulting in the production of
an apurinic site [19,20,52,53]. Overexpression of MPG
causes an imbalance in DNA repair and an increase in
the number of abasic sites, which can ultimately lead to
double-stranded breaks and chromosomal aberrations
[21,54,55]. Furthermore, MPG null cells have chromoso-
mal aberrations and increased apoptosis [56]. Thus, a
Figure 6 Expression of TrxR in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using a TrxR-specific antibody.
Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n = 16),
DCIS (n = 15) or IBC (n = 20) section and is shown graphically. The intensity of normal mammary tissue is equal to one (dashed line).
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DCIS and IBC, could cause an imbalance in DNA repair
resulting in decreased DNA damage recognition and
reduced DNA repair. The loss of MPG expression in
breast cancer cells could potentially enhance the effec-
tiveness of alkylating agents such as those used in che-
motherapy by limiting DNA repair and enhancing
apoptosis.
In addition to its role in redox regulation, Ape1/Ref-1
recognizes abasic sites produced by DNA glycosylases
and nicks the DNA backbone to continue the DNA
repair process [19,20]. Although the increased expres-
sion of Ape1/Ref-1 would suggest that the DNA back-
bone would be effectively nicked at apurinic sites, the
redistribution of Ape1/Ref-1 from the nucleus to the
cytoplasm would limit this process.
It has been suggested that NM23-H1 may have an
intrinsic capacity to nick DNA and, in so doing, to initi-
ate DNA repair or apoptosis (Fig. 1 and Refs [57,58]).
NM23-H1 was initially characterized as a nonmetastatic
factor [27,59-62]. Previous studies from our laboratory
demonstrated that decreased expression of NM23-H1 in
MCF-7 breast cancer cells enhances expression of
Cathepsin D and Bcl2, which are involved in limiting
apoptosis, promoting cell migration and increasing
angiogenesis [26]. In contrast, overexpression of NM23-
H1 in a metastatic breast cancer cell line [61,63,64] or
injection of NM23-H1-conjugated nanoparticles into
mouse xenographs results in a loss of invasiveness [65].
Likewise, as demonstrated in the current study, those
breast tumors with the highest NM23-H1 expression
were less likely to have migrated to the lymph nodes.
Figure 7 Expression of PDI in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using a PDI-specific antibody.
Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n = 16),
DCIS (n = 15) or IBC (n = 22) section and is shown graphically. ANOVA was used to detect statistical differences in the relative expression of BH
(p = 0.0003), DCIS (p = 0.0002) and IBC (p = 0.0007) compared to normal mammary tissue, where normal mammary tissue is equal to one
(dashed line). C. The relative mean intensity of IBC tissues was graphed according to ERa-status. D. Cellular localization of PDI expression was
determined for each tissue section, classified by disease state and shown graphically (N, nuclear; C, cytoplasmic; N+C, nuclear and cytoplasmic).
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endogenous or exogenous alkylating agents and must be
repaired in order to maintain genomic integrity. Earlier
studies revealed that 8-OxoG lesions were increased in
IBC compared to adjacent normal mammary tissue
[66,67] and that 8-OxoG lesions accumulate with age
[68]. Interestingly, we observed an increase in 8-OxoG
content in ERa-positive, but not ERa-negative IBC.
We had anticipated that DNA and/or protein damage
might be increased in IBC. However, no significant
increases in 8-OxoG, g-H2AX or nitrotyrosine levels
were observed in BH, DCIS or IBC compared with nor-
mal mammary tissue. It should however be noted that
we were unable to detect any staining with the 8-OxoG,
g-H2AX or nitrotyrosine antibodies in normal human
mammary tissue and that IBC tissues had to be utilized
to define appropriate IHC conditions. Interestingly, we
did detect a concomitant increase in g-H2AX, 8-OxoG
and nitrotyrosine in a subset of BH tissues suggesting
that the limited expression of oxidative stress and DNA
repair proteins in these tissues might leave them more
susceptible to protein and DNA damage.
In normal cells, excess superoxide reacts with nitric
oxide to produce peroxynitrite, which in turn leads to
nitration of tyrosine residues (Fig. 1 and Refs[69,70]).
One way that the intracellular nitrotyrosine levels may
be reduced in IBC to the level found in normal mam-
mary tissue is by the increased expression and/or activ-
ity of SOD1. In fact, increased expression of SOD1,
Ape1/Ref-1 and Trx in IBC could collectively help to
Figure 8 Expression of NM23-H1 in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using an NM23-H1-specific antibody.
Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each BH (n = 16),
DCIS (n = 16) or IBC (n = 25) section and is shown graphically. ANOVA was used to detect statistical differences in the relative expression of BH,
DCIS (p = 0.0019) and IBC (p < 0.0001) compared to normal mammary tissue, where normal mammary tissue is equal to one (dashed line). C. The
relative mean intensity of IBC tissues was graphed according to nodal-status.
Figure 9 Expression of MPG in normal, BH, DCIS and IBC tissue.
A. Tissues were subjected to IHC using an MPG-specific antibody.
Representative slides are shown at 40× magnification. B. The relative
mean intensity was determined from 6-8 images for each BH (n =
16), DCIS (n = 16) or IBC (n = 21) section and is shown graphically.
ANOVA was used to detect statistical differences in the relative
expression of BH (p = 0.0002), DCIS (p < 0.0001) and IBC (p <
0.0001) compared to normal mammary tissue, where normal
mammary tissue is equal to one (dashed line).
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and promote tumor cell survival.
Conclusions
We have shown that SOD1, Ape1/Ref-1, Trx, PDI and
NM23-H1 are overexpressed, and that the cellular loca-
lization of Ape1/Ref-1, Trx, and PDI is altered in
human breast cancer tissue. Our studies suggest that
oxidative stress proteins (SOD1, Ape1/Ref-1, Trx, and
PDI) and the DNA repair protein Ape1/Ref-1 not only
protect normal cells from the damaging effects of ROS,
but also promote survival of mammary tumor cells and
foster tumor progression. Furthermore, overexpression
of oxidative stress (SOD1, Ape1/Ref-1, Trx, and PDI)
and DNA repair (MPG and Ape1/Ref-1) proteins has
been shown to provide resistance to chemotherapeutic
agents and impede cancer treatment [14,49,71-75].
Thus, targeting these proteins may provide an additional
method of sensitizing cancer cells prior to administra-
tion of chemotherapeutic agents and aid in the develop-
ment of more effective treatment regimes.
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Figure 10 Analysis of the DNA lesion, 8-OxoG, in normal, BH, DCIS and IBC tissue. A. Tissues were subjected to IHC using an 8-OxoG-
specific antibody. Representative slides are shown at 40× magnification. B. The relative mean intensity was determined from 6-8 images for each
BH (n = 15), DCIS (n = 15) or IBC (n = 19) section and is shown graphically. The intensity of normal mammary tissue is equal to one (dashed
line). C. The relative mean intensity of IBC tissues was graphed according to ERa-status.
Figure 11 Expression of g-H2AX in normal, BH, DCIS and IBC
tissue. A. Tissues were subjected to IHC using a g-H2AX-specific
antibody. Representative slides are shown at 40× magnification. B.
The relative mean intensity was determined from 6-8 images for
each BH (n = 16), DCIS (n = 16) or IBC (n = 22) section and is
shown graphically. The intensity of normal mammary tissue is equal
to one (dashed line).
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